The Eye Center, Riyadh (Saudi Arabia) Report issue

Academic/Hospital Phase 1

Organization Overview

First Clinical Trial
2002
NCT00357292
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2002

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 1 Trials (1)

azithromycin (zithromax) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Bacterial Infections (Phase 1)

Eye Infections (Phase 1)

Eye Infections, Bacterial (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 1